BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33631508)

  • 1. Evaluation of the cognitive impairments and depressive symptoms in patients with Parkinson's disease: A case-control study from Iran.
    Sinaeefar MJ; Saadat P; Hamidia A; Hosseini SR
    Clin Neurol Neurosurg; 2021 Apr; 203():106549. PubMed ID: 33631508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex- and age-specific prevalence and risk factors of depressive symptoms in Parkinson's disease.
    Niu L; Yao C; Zhang C; Zhou C; Fu Y; Li Y; Yang H; Sun X; Yang J; Zhao P; Yi S; Wang T; Li S; Li J
    J Neural Transm (Vienna); 2023 Oct; 130(10):1291-1302. PubMed ID: 37418038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Impairment and Mortality in a Population-Based Parkinson's Disease Cohort.
    Keener AM; Paul KC; Folle A; Bronstein JM; Ritz B
    J Parkinsons Dis; 2018; 8(2):353-362. PubMed ID: 29843251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression in Parkinson's disease: clinical correlates and outcome.
    Rojo A; Aguilar M; Garolera MT; Cubo E; Navas I; Quintana S
    Parkinsonism Relat Disord; 2003 Oct; 10(1):23-8. PubMed ID: 14499203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in Parkinson's disease: a cross-sectional study focusing on non-motor symptoms.
    Kadastik-Eerme L; Rosenthal M; Paju T; Muldmaa M; Taba P
    Health Qual Life Outcomes; 2015 Jun; 13():83. PubMed ID: 26088201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.
    Lee PC; Artaud F; Cormier-Dequaire F; Rascol O; Durif F; Derkinderen P; Marques AR; Bourdain F; Brandel JP; Pico F; Lacomblez L; Bonnet C; Brefel-Courbon C; Ory-Magne F; Grabli D; Klebe S; Mangone G; You H; Mesnage V; Brice A; Vidailhet M; Corvol JC; Elbaz A;
    Mov Disord; 2019 Nov; 34(11):1663-1671. PubMed ID: 31518456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in cognition among Chinese people with Parkinson's disease.
    Gao L; Nie K; Tang H; Wang L; Zhao J; Gan R; Huang J; Feng S; Zhu R; Duan Z; Zhang Y; Wang L
    J Clin Neurosci; 2015 Mar; 22(3):488-92. PubMed ID: 25595960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depression in Parkinson's disease: clinical-epidemiological correlates and comparison with a controlled group of non-parkinsonian geriatric patients.
    Veiga BA; Borges V; Silva SM; Goulart Fde O; Cendoroglo MS; Ferraz HB
    Braz J Psychiatry; 2009 Mar; 31(1):39-42. PubMed ID: 19506774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interlocking finger test in patients with Parkinson's disease and healthy subjects.
    Souza CP; Oliveira GN; Foss MP; Tumas V
    J Clin Neurosci; 2016 Jul; 29():145-8. PubMed ID: 26960261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of depressive symptoms among spouse caregivers in Parkinson's disease.
    Fernandez HH; Tabamo RE; David RR; Friedman JH
    Mov Disord; 2001 Nov; 16(6):1123-5. PubMed ID: 11748746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlates of depressive symptoms in familial Parkinson's disease.
    Pankratz N; Marder KS; Halter CA; Rudolph A; Shults CW; Nichols WC; Foroud T;
    Mov Disord; 2008 Nov; 23(15):2216-23. PubMed ID: 18785635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
    Ojagbemi A
    J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy markers, cognitive deficits and depressive symptoms in Parkinson's disease.
    Li Y; Yang H; Zhao P; Yang J; Yao C; Zhou C; Yang C; Sun X; Li S; Li J
    J Neural Transm (Vienna); 2024 Jan; 131(1):73-81. PubMed ID: 37801108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of depressive symptoms in patients with incident Parkinson's disease: a prospective cohort study.
    Larsen JP; Dalen I; Pedersen KF; Tysnes OB
    J Neurol; 2017 Dec; 264(12):2401-2408. PubMed ID: 29032408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmotor Symptoms and Cognitive Decline in de novo Parkinson's Disease.
    Kwon KY; Kang SH; Kim M; Lee HM; Jang JW; Kim JY; Lee SM; Koh SB
    Can J Neurol Sci; 2014 Sep; 41(5):597-602. PubMed ID: 25373810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.